Retatrutide
TRIUMPH-5
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Retatrutide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Tirzepatide | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Retatrutide
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Retatrutide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Tirzepatide | Obesity or overweight | n/r | n/r | n/r | n/r |